[The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000378:metabolism; D001323:Autoantibodies; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use; D013156:Splenectomy / Q000009:adverse effects
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D001623:Betamethasone; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate
Le traitement du lupus érythémateux disséminé. Médicaments dits immunosuppressifs.